{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:57:13Z","timestamp":1775228233861,"version":"3.50.1"},"reference-count":45,"publisher":"Biomedical Research Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2025,9,26]]},"DOI":"10.2220\/biomedres.46.203","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:07Z","timestamp":1759010887000},"page":"203-214","source":"Crossref","is-referenced-by-count":1,"title":["Muscular USP2 is dispensable for MASLD-associated disorders in the liver and skeletal muscle in mice"],"prefix":"10.2220","volume":"46","author":[{"given":"Aya","family":"IIDA","sequence":"first","affiliation":[{"name":"Laboratory of Disease Models, School of Veterinary Medicine, Rakuno Gakuen University, 582 Midori-machi, Bunkyo-dai, Ebetsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"FUJIMOTO","sequence":"additional","affiliation":[{"name":"Laboratory of Disease Models, School of Veterinary Medicine, Rakuno Gakuen University, 582 Midori-machi, Bunkyo-dai, Ebetsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"KITAMURA","sequence":"additional","affiliation":[{"name":"Department of Laboratory Animal Medicine Tohoku University Graduate School of Medicine 2-1 Seiryo-machi Aoba-ku Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ahmed H, Umar MI, Imran S, Javaid F, Syed SK, <i>et al.<\/i> (2022) TGF-\u03b21 signaling can worsen NAFLD with liver fibrosis backdrop. <i>Exp Mol Pathol<\/i> <b>124<\/b>, 104733.","DOI":"10.1016\/j.yexmp.2021.104733"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O and Heikenwalder M (2019) From NASH to HCC: current concepts and future challenges. <i>Nat Rev Gastroenterol Hepatol<\/i> <b>16<\/b>, 411\u2013428.","DOI":"10.1038\/s41575-019-0145-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bett JS (2016) Proteostasis regulation by the ubiquitin system. <i>Essays Biochem<\/i> <b>60<\/b>, 143\u2013151.","DOI":"10.1042\/EBC20160001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chen X, Ji Y, Liu R, Zhu X, Wang K, <i>et al.<\/i> (2023) Mitochondrial dysfunction: roles in skeletal muscle atrophy. <i>J Transl Med<\/i> <b>21<\/b>, 1\u201324.","DOI":"10.1186\/s12967-023-04369-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cooreman MP, Vonghia L and Francque SM (2024) MASLD\/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists. <i>Diabetes Res Clin Pract<\/i> <b>212<\/b>, 111688.","DOI":"10.1016\/j.diabres.2024.111688"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cris\u0327an D, Avram L, Morariu-Barb A, Grapa C, Hiris\u0327cau I, <i>et al.<\/i> (2025) Sarcopenia in MASLD\u2014Eat to Beat Steatosis, Move to Prove Strength. <i>Nutrients<\/i> <b>17<\/b>, 1\u201320.","DOI":"10.3390\/nu17010178"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Davis MI, Pragani R, Fox JT, Shen M, Parmar K, <i>et al.<\/i> (2016) Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. <i>J Biol Chem<\/i> <b>291<\/b>, 24628\u201324640.","DOI":"10.1074\/jbc.M116.738567"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, <i>et al.<\/i> (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. <i>J Hepatol<\/i> <b>39<\/b>, 967\u2013971.","DOI":"10.1016\/S0168-8278(03)00459-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fujimoto M, Iwasaki T, Hosotani Saito M, Takahashi N, Hashimoto M, <i>et al.<\/i> (2025) Suppression of USP2 in mouse skeletal muscle: a model of oxidative stress in muscle tissue. <i>Exp Anim<\/i>, <i>in press<\/i>.","DOI":"10.1538\/expanim.25-0032"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Gao J, Qian T and Wang W (2020) CTRP3 activates the AMPK\/SIRT1-PGC-1\u03b1 pathway to protect mitochondrial biogenesis and functions in cerebral ischemic stroke. <i>Neurochem Res<\/i> <b>45<\/b>, 3045\u20133058.","DOI":"10.1007\/s11064-020-03152-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gousseva N and Baker RT (2003) Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69. <i>Gene Expr<\/i> <b>11<\/b>, 163\u2013179.","DOI":"10.3727\/000000003108749053"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Graner E, Tang D, Rossi S, Baron A, Migita T, <i>et al.<\/i> (2004) The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. <i>Cancer Cell<\/i> <b>5<\/b>, 253\u2013261.","DOI":"10.1016\/S1535-6108(04)00055-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hammerich L and Tacke F (2023) Hepatic inflammatory responses in liver fibrosis. <i>Nat Rev Gastroenterol Hepatol<\/i> <b>20<\/b>, 633\u2013 646.","DOI":"10.1038\/s41575-023-00807-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hashimoto M, Fujimoto M, Konno K, Lee ML, Yamada Y, <i>et al.<\/i> (2022) Ubiquitin-specific protease 2 in the ventromedial hypothalamus modifies blood glucose levels by controlling sympathetic nervous activation. <i>J Neurosci<\/i> <b>42<\/b>, 4607\u20134618.","DOI":"10.1523\/JNEUROSCI.2504-21.2022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hashimoto M, Kimura S, Kanno C, Yanagawa Y, Watanabe T, <i>et al.<\/i> (2021) Macrophage ubiquitin-specific protease 2 contributes to motility, hyperactivation, capacitation, and in vitro fertilization activity of mouse sperm. <i>Cell Mol Life Sci<\/i> <b>78<\/b>, 2929\u20132948.","DOI":"10.1007\/s00018-020-03683-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hashimoto M, Saito N, Ohta H, Yamamoto K, Tashiro A, <i>et al.<\/i> (2019) Inhibition of ubiquitin-specific protease 2 causes accumulation of reactive oxygen species, mitochondria dysfunction, and intracellular ATP decrement in C2C12 myoblasts. <i>Physiol Rep<\/i> <b>7<\/b>, 1\u201314.","DOI":"10.14814\/phy2.14193"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Herms A, Bosch M, Ariotti N, Reddy BJN, Fajardo A, <i>et al.<\/i> (2013) Cell-to-cell heterogeneity in lipid droplets suggests a mechanism to reduce lipotoxicity. <i>Curr Biol<\/i> <b>23<\/b>, 1489\u20131496.","DOI":"10.1016\/j.cub.2013.06.032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Horn P and Tacke F (2024) Metabolic reprogramming in liver fibrosis. <i>Cell Metab<\/i> <b>36<\/b>, 1439\u20131455.","DOI":"10.1016\/j.cmet.2024.05.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Jiang F, Chen Q, Wang W, Ling Y, Yan Y, <i>et al.<\/i> (2020) Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1. <i>J Hepatol<\/i> <b>72<\/b>, 156\u2013166.","DOI":"10.1016\/j.jhep.2019.09.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, <i>et al.<\/i> (2018) Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model. <i>Horm Metab Res<\/i> <b>50<\/b>, 80\u201387.","DOI":"10.1055\/s-0043-118666"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kim JA and Choi KM (2019) Sarcopenia and fatty liver disease. <i>Hepatol Int<\/i> <b>13<\/b>, 674\u2013687.","DOI":"10.1007\/s12072-019-09996-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Kitamura H (2023) Ubiquitin-specific proteases (USPs) and metabolic disorders. <i>Int J Mol Sci<\/i> <b>24<\/b>, 3219.","DOI":"10.3390\/ijms24043219"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Kitamura H and Hashimoto M (2021) USP2-related cellular signaling and consequent pathophysiological outcomes. <i>Int J Mol Sci<\/i> <b>22<\/b>, 1209.","DOI":"10.3390\/ijms22031209"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kitamura H, Ishino T, Shimamoto Y, Okabe J, Miyamoto T, <i>et al.<\/i> (2017) Ubiquitin-specific protease 2 modulates the lipopolysaccharide-elicited expression of proinflammatory cytokines in macrophage-like HL-60 cells. <i>Mediators Inflamm<\/i> <b>2017<\/b>, 6909415.","DOI":"10.1155\/2017\/6909415"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Kitamura H, Kimura S, Shimamoto Y, Okabe J, Ito M, <i>et al.<\/i> (2013) Ubiquitin-specific protease 2-69 in macrophages p tentially modulates metainflammation. <i>FASEB J<\/i> <b>27<\/b>, 4940\u2013 4953.","DOI":"10.1096\/fj.13-233528"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, <i>et al.<\/i> (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. <i>Hepatology<\/i> <b>41<\/b>, 1313\u20131321.","DOI":"10.1002\/hep.20701"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Kubat GB, Bouhamida E, Ulger O, Turkel I, Pedriali G, <i>et al.<\/i> (2023) Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies. <i>Mitochondrion<\/i> <b>72<\/b>, 33\u201358.","DOI":"10.1016\/j.mito.2023.07.003"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Li C, Li M, Sheng W, Zhou W, Zhang Z, <i>et al.<\/i> (2024) High dietary fructose drives metabolic dysfunction-associated steatotic liver disease via activating ubiquitin-specific peptidase 2\/11\u03b2-hydroxysteroid dehydrogenase type 1 pathway in mice. <i>Int J Biol Sci<\/i> <b>20<\/b>, 3480\u20133496.","DOI":"10.7150\/ijbs.97309"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Marjot T, Armstrong MJ and Stine JG (2025) Skeletal muscle and MASLD: Mechanistic and clinical insights. <i>Hepatol Commun<\/i> <b>9<\/b>, e0711.","DOI":"10.1097\/HC9.0000000000000711"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Matsuda T, Kaji K, Nishimura N, Asada S, Koizumi A, <i>et al.<\/i> (2024) Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity. <i>Heliyon<\/i> <b>10<\/b>, e38647.","DOI":"10.1016\/j.heliyon.2024.e38647"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, <i>et al.<\/i> (2013) An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. <i>Int J Exp Pathol<\/i> <b>94<\/b>, 93\u2013103.","DOI":"10.1111\/iep.12008"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Miao L, Targher G, Byrne CD, Cao YY and Zheng MH (2024) Current status and future trends of the global burden of MASLD. <i>Trends Endocrinol Metab<\/i> <b>35<\/b>, 697\u2013707.","DOI":"10.1016\/j.tem.2024.02.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Molusky MM, Li S, Ma D, Yu L and Lin JD (2012) Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11&amp;beta-hydroxysteroid dehydrogenase 1. <i>Diabetes<\/i> <b>61<\/b>, 1025\u20131035.","DOI":"10.2337\/db11-0970"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Nelson JK, Sorrentino V, Trezza RA, Heride C, Urbe S, <i>et al.<\/i> (2016) The deubiquitylase USP2 regulates the ldlr pathway by counteracting the E3-Ubiquitin Ligase IDOL. <i>Circ Res<\/i> <b>118<\/b>, 410\u2013419.","DOI":"10.1161\/CIRCRESAHA.115.307298"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Parthasarathy G, Revelo X and Malhi H (2020) Pathogenesis of nonalcoholic steatohepatitis: An overview. <i>Hepatol Commun<\/i> <b>4<\/b>, 478\u2013492.","DOI":"10.1002\/hep4.1479"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Peterson JM, Wei Z and Wong GW (2010) C1q\/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. <i>J Biol Chem<\/i> <b>285<\/b>, 39691\u201339701.","DOI":"10.1074\/jbc.M110.180695"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Saito N, Kimura S, Miyamoto T, Fukushima S, Amagasa M, <i>et al.<\/i> (2017) Macrophage ubiquitin-specific protease 2 modifies insulin sensitivity in obese mice. <i>Biochem Biophys Rep<\/i> <b>9<\/b>, 322\u2013329.","DOI":"10.1016\/j.bbrep.2017.01.009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, <i>et al.<\/i> (2019) Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. <i>Life Sci<\/i> <b>228<\/b>, 251\u2013257.","DOI":"10.1016\/j.lfs.2019.05.014"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Syed-Abdul MM (2024) Lipid metabolism in metabolic-associated steatotic liver disease (MASLD). <i>Metabolites<\/i> <b>14<\/b>, 12. Takahashi H, Yamanaka S, Kuwada S, Higaki K, Kido K, <i>et al.<\/i>","DOI":"10.3390\/metabo14010012"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yang S, Xiong L, Liao T, Li L, Li Y, <i>et al.<\/i> (2025) Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPAR\u03b3. <i>Diabetes<\/i> <b>74<\/b>, 773\u2013786.","DOI":"10.2337\/figshare.28270730.v1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Kitamura H, Fujimoto M, Hashimoto M, Yasui H and Inanami O (2024) USP2 mitigates reactive oxygen species-induced mitochondrial damage via UCP2 expression in myoblasts. Int J Mol Sci 25, 11936.","DOI":"10.3390\/ijms252211936"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Li X, He J and Sun Q (2024) The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Clin Nutr 43, 2005\u20132016.","DOI":"10.1016\/j.clnu.2024.07.006"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Ye Y, Scheel H, Hofmann K and Komander D (2009) Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst 5, 1797\u20131808.","DOI":"10.1039\/b907669g"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Zhang CL, Feng H, Li L, Wang JY, Wu D, et al. (2017) Globular CTRP3 promotes mitochondrial biogenesis in cardiomyocytes through AMPK\/PGC-1\u03b1 pathway. Biochim Biophys Acta \u2013 Gen Subj 1861, 3085\u20133094.","DOI":"10.1016\/j.bbagen.2016.10.022"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Takahashi H, Yamanaka S, Kuwada S, Higaki K, Kido K, et al. (2020) A human DUB protein array for clarification of linkage specificity of polyubiquitin chain and application to evaluation of its inhibitors. Biomedicines 8, 1\u201313.","DOI":"10.3390\/biomedicines8060152"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/46\/5\/46_203\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:47:09Z","timestamp":1759549629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/46\/5\/46_203\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.46.203","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}